Podcasts about prasad

Amardeep Parmar from Bae HQ welcomes Shubhanga Prasad, Cofounder and GP at Aagama Ventures.Amardeep Parmar:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/amardeepsparmar⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Shubhanga Prasad: https://www.linkedin.com/in/shubhangaprasad/Aagama Ventures: https://aagama.vc/

What does it take to build startups with the speed of a founder and the scale of a global enterprise? Shilpa Prasad shares how LG Nova is rethinking venture creation by combining corporate resources with a venture studio model designed to launch AI-native businesses. The conversation explores how emerging AI opportunities are identified, why founder talent often matters more than the initial idea, and what separates ventures with billion-dollar potential from the rest. Shilpa also discusses the evolving relationship between startups and large corporations, how AI is changing the commercialization journey, and why access to strategic partnerships, capital, and industry networks can accelerate growth. Drawing on her experience leading AI incubation at LG Nova, she offers a behind-the-scenes look at how one of the world's largest technology companies is building the next generation of businesses. Whether you're a founder, investor, or corporate innovation leader, this episode provides valuable insights into the future of venture creation and AI-driven innovation.

At Contact in the Desert, Martin Willis sits down with entrepreneur, AI researcher, and quantum computing expert Deep Prasad for a wide-ranging discussion that explores the intersection of artificial intelligence, consciousness, advanced physics, and the UFO phenomenon. Deep shares details of an extraordinary experience he had in 2019 that profoundly changed his understanding of reality and led him to explore questions surrounding non-human intelligence and consciousness. He also discusses the rapid advancement of AI, the promise and challenges of quantum computing, and how future technologies may help unlock some of the deepest mysteries surrounding UAP.SHOW NOTESCONTACT AND SUPPORT

Being a Brush in Baba's HandsFour decades ago, inspired by Bhagawan Himself, Mr B K Prasad embarked on a remarkable artistic journey by painting portraits of Swami. His very first painting was blessed by Swami in 1987.  Since then, he has created more than 160 breathtaking portraits of both Shirdi Sai and Sathya Sai, each reflecting not merely artistic skill but profound devotion.Looking back, Mr Prasad feels that his journey has been far more than an exploration of art, it has indeed been a path to self-realisation and salvation. “Painting Swami is nothing but meditation for me,” he says. “In truth, I am not the one holding the brush; it is Swami who holds me. Otherwise, forget painting, I would not even be standing or breathing today.”Among the countless blessings he has received, one remains especially precious: Bhagawan's words, “Your paintings look like photographs.” In this Satsang, Mr Prasad takes us through his extraordinary journey of self-discovery through oil, paint, and brush, sharing how devotion transformed his art into a spiritual sadhana.Professionally, Mr Prasad is a certified Cost Accountant who has enjoyed a distinguished career in senior management roles across finance and information technology with several multinational corporations.

The ongoing conflict between Iran, the US and Israel has not only led to the deaths of many thousands of people, it has destabilised the global world order. As a middle power, Australia is being drawn into the conflict amid global pressures and strategic resource dependencies. Closer to home, the conflict is having a destabilising impact on Australia’s economy and enhancing other ongoing issues, such as rising inflation and concerns of higher unemployment. UNSW’s Nalini Prasad explains how global and domestic trends in the economy are impacting the Aussie wallet, and your standard of living. She will explain how these trends are threatening an economic situation called ‘stagflation’, unseen since the 1970s and difficult to solve through traditional policy levers.See omnystudio.com/listener for privacy information.

To my sons Rory and Lucas — this episode is really a letter to you boys. One day you may look back at these soccer decisions and think I was wise… or completely clueless. But I hope you'll always know they came from love, thought, prayer, and a deep desire to help you become fully yourselves — not just better athletes.In this conversation with Coach Hayden Prasad, we talk about youth sports, burnout, joy, pressure, creativity, character, and what actually helps kids thrive long term. More than anything, I hope this reminds you that I never cared most about trophies or status — I cared about our time together, your love for the game, and the men you're becoming.Instagram: @roycelaguertaWebsite: https://www.nvfitt.comEmail: hello@nvfitt.comSupport the Show: https://www.buzzsprout.com/862429/sup...Key Moments01:07 - Chapter 1: The kids who make it and the kids who don't.16:15 - Chapter 2: Don't let development steal their joy.25:31- Chapter 3: The principles guiding my sons.Support the show

Jonathan Howard and Wendy Orent call this week their "Red Wedding": within days, FDA Commissioner Marty Makary resigned, Vinay Prasad was pushed out of CBER, Tracy Beth Hoeg was fired, and Senator Bill Cassidy lost his Louisiana primary. The hosts argue this is not a tragedy but a long-foretold collapse — a group of physicians who built careers as COVID-era contrarian podcasters discovering that running a regulatory agency is fundamentally different from posting about one. Howard works through the wreckage: Makary's reported approval of flavored nicotine products days before his ouster, the FDA's treatment of the rare disease community, the leaked memo claiming pediatric COVID vaccine deaths that career staff refused to sign off on, and the broader pattern of "regulatory whiplash" that drove the agency into dysfunction. The episode then turns to who is still standing — Jay Bhattacharya at NIH, Robert F. Kennedy Jr. at HHS — and what Kennedy is reportedly doing to vaccines from behind the scenes via Martin Kulldorff's review effort. Throughout, the hosts return to a single thesis: the skills that made Makary, Prasad, Hoeg, and Cassidy famous during COVID — opinion, tweeting, posturing — do not translate into running institutions, and the medical commentators who vouched for them (John Mandrola, Adam Cifu) have lost any remaining credibility. Key Topics Discussed Bill Cassidy's primary loss and the cost of the Kennedy confirmation vote Cassidy's earlier vote to convict Trump after January 6 followed by his decisive vote advancing RFK Jr. as HHS Secretary. Howard and Orent's view that Cassidy's promise to "keep Kennedy in line" was hollow from the start. What Cassidy's defeat signals about Trump's grip on the Republican base in Louisiana — and the hosts' read that his lame-duck status may give him cover to block the next round of HHS nominees. Marty Makary's resignation and the "worst FDA Commissioner in 25 years" framing The Stat News piece characterizing Makary's tenure, and the reporting that flavored nicotine was the precipitating issue with Trump's tobacco-industry donors. Howard's counterpoint: Makary reportedly approved a batch of electronic nicotine delivery systems (ENDS) on May 5, 2026 — the weekend before he resigned — undercutting the "principled stand" narrative. The pattern of selfie videos, public-facing performance, and what former FDA staff describe as hostile management of career scientists. Makary's pre-FDA record: the "medical error is the third leading cause of death" claim, Omicron as "nature's vaccine," "Omicold," herd immunity calls in May 2021, and the Nazi-bioweapon Lyme disease theory amplification. Vinay Prasad, regulatory whiplash, and the rare disease community How Prasad's stated preference for randomized controlled trials translated into rejection of rare disease therapies — and the disconnect between calling for RCTs on Twitter and the practical impossibility of running them for small patient populations. Right-to-try advocates, the libertarian wing of MAHA (Senator Ron Johnson), and why they turned on Prasad. Howard's point: Pfizer's halted COVID vaccine RCT in 50–65-year-olds is the case study — the trials Prasad demanded couldn't actually be enrolled. Tracy Beth Hoeg, the leaked pediatric deaths memo, and the Maryanne Demasi interview Hoeg's insistence she was fired, not resigned, and her interview with Brownstone Institute–adjacent journalist Maryanne Demasi. Her claim that the chaos at the FDA was "created by the media" rather than real. The memo alleging 10 pediatric deaths from the COVID vaccine that career FDA staff would not sign off on — and Howard's contrast with the J&J/thrombosis response, where nine deaths produced immediate, transparent action. Hoeg's role in the Denmark-style vaccine schedule rollback memo alongside Makary. The Makary–Prasad ZDoggMD clip on FDA "vindictiveness" — and the irony Audio pulled from a pre-appointment Prasad/Makary appearance describing the FDA as "erratic," "capricious," and politically pressured. Howard's read: every criticism they leveled at the Biden-era FDA describes their own tenure — political pressure from Trump, demoted career staff, inconsistent standards. The Peter Marks / Marion Gruber / Phil Krause booster episode reframed in light of what followed. John Mandrola, Adam Cifu, and the cost of vouching Mandrola's "Can We Give the New FDA's Leadership a Chance?" piece a year earlier — and the line about Prasad and Makary inducing companies to run proper RCTs, set against Pfizer's halted trial. Howard's account of an email exchange with Cifu following Cifu's visit to NYU — Howard's offer of a serious content-level conversation, and Cifu's decline. The broader "medical conservatives" project and what the hosts argue has happened to its credibility. Jay Bhattacharya, NIH, and the resignation letter from departing staff The letter from a senior NIH scientist on Bhattacharya's leadership — political termination of grants, deals institutions are making to recover funding, and Bhattacharya's silence. Howard and Orent's read on Bhattacharya's visible deterioration and his retreat into Great Barrington nostalgia. Kennedy's behind-the-scenes vaccine review and Martin Kulldorff The New York Times reporting (Christina Jewett and Sheryl Gay Stolberg) on Kennedy's vaccine inquiry being led by Kulldorff. Howard's pushback on the framing of Kulldorff as merely "a critic of restrictions and mandates" — and the 2020 record of his herd-immunity-through-infection advocacy, including his Stockholm "almost at herd immunity" claim in April 2020. The hosts' concern that the COVID amnesia project lets pandemic-era pro-infection figures re-enter regulatory power with their record sanitized. Casey Means, Surgeon General nomination withdrawal, and MAHA fracturing The withdrawn Surgeon General nomination and what it signals. The Robert Malone vs. Makary public falling-out over the unreleased pediatric deaths data. Why the MAHA coalition — held together by shared COVID grievance — is coming apart now that COVID has receded from headlines. Notable Moments On Cassidy: "He betrayed his oath as a physician, he betrayed the American people, and he's going down into the ignominious dust." — Wendy Orent On the Makary–Prasad–Hoeg trio: "The same skill sets that catapulted these guys to power — essentially being excellent podcasters — do not translate into leading a government agency of tens of thousands of employees that regulates 20 percent of the US economy." — Jonathan Howard On the legacy: "These guys are now cautionary tales for medical students. I would love to teach a course called 'Be the Opposite of Bill Cassidy, Marty Makary, Vinay Prasad, and Tracy Beth Hoeg.'" — Jonathan Howard On Bhattacharya: "His soul has been totally corrupted by the people who he teamed up with. You also see it in his face. He's not the same person that took the position." — Jonathan Howard References Mentioned in the Episode Stat News — "Why Marty Makary Was the Worst FDA Commissioner in 25 Years" Vinay Prasad's 2016 Stat News rebuttal of Makary's "medical error" claim David Gorski (Science-Based Medicine, 2016) — rebuttal of the medical-error-as-third-leading-cause-of-death claim Jonathan Howard, Science-Based Medicine — recent piece compiling Makary's COVID-era statements New York Times — Christina Jewett and Sheryl Gay Stolberg on Kennedy's vaccine inquiry Washington Post — "Ouster of RFK's Allies Tests MAHA-Trump Alliance" Ben Mazer, The Atlantic — on whether Makary and Prasad enacted lasting change Francis Lee — In COVID's Wake Alfred Crosby — America's Forgotten Pandemic Maryanne Demasi interview with Tracy Beth Hoeg MedPage Today — Makary and Prasad, "The Importance of Humility in Medicine" People Referenced Marty Makary — outgoing FDA Commissioner Vinay Prasad — former CBER Director Tracy Beth Hoeg — fired FDA official Senator Bill Cassidy (R-LA) — lost primary Robert F. Kennedy Jr. — HHS Secretary Jay Bhattacharya — NIH Director Martin Kulldorff — leading Kennedy's vaccine review Peter Marks — former CBER Director, Operation Warp Speed Bob Kadlec — Operation Warp Speed David Kessler — former FDA Commissioner (referenced) Marion Gruber and Phil Krause — former FDA vaccine reviewers John Mandrola and Adam Cifu — "medical conservative" commentators Robert Malone — anti-vaccine activist Casey Means — withdrawn Surgeon General nominee Senator Ron Johnson (R-WI) Representative Jake Auchincloss — opened FDA whistleblower line Art Caplan — bioethicist (retirement) Erica Schwartz — CDC Director nominee, unconfirmed  

Senkt vegane Ernährung den Testosteronspiegel – oder ist das nur ein Fitness-Mythos? In dieser Folge sprechen wir über Testosteron, Soja, Cholesterin, Muskelaufbau, Krafttraining, Energiedefizite, Blutwerte und den wachsenden Trend rund um TRT. Wissenschaftlich eingeordnet, praxisnah erklärt und mit Blick darauf, was für vegane Sportlerinnen und Sportler wirklich relevant ist. ------------------------------------------------------------------------ Dominiks Buch zur pflanzenbasierten Sporternährung im UTB-Verlag: https://www.utb.de/doi/book/10.36198/9783838560328 Dominiks Gesundheitscommunity: www.gsundes-hannover.de Dominiks Online-Knie-Kurs: https://gsundes-hannover.de/knieschmerzen/ Dominiks Online-Rücken-Kurs: https://copecart.com/products/34bd5abb/checkout Marcs veganes Online-Fitness-Coaching: https://vegainer-academy.com/ Marcs Online-Kurs: https://www.copecart.com/products/a50f88f2/checkout ------------------------------------------------------------------------ Dieser Podcast wird unterstützt von der Firma Watson Nutrition. Die Firma bietet als einzige umfassend laborgeprüfte Nahrungsergänzungsmittel für eine optimierte Nährstoffversorgung. Zum Angebot zählen Multi-Supplemente, Mono-Supplemente, Sportsupplemente wie Kreatin oder auch Proteinriegel, Shakes und essenzielle Aminosäuren Mit dem Code veganperformance erhältst du 5 % Rabatt auf deine Bestellung.  Zur Firmenwebseite: Watson Nutrition ------------------------------------------------------------------------ Quellen: Wissenschaftliche Studien, Reviews und Leitlinien Allen, N. E., Appleby, P. N., Davey, G. K., & Key, T. J. (2000). Hormones and diet: Low insulin-like growth factor-I but normal bioavailable androgens in vegan men. British Journal of Cancer, 83(1), 95–97. Baillargeon, J., Kuo, Y. F., Westra, J. R., Urban, R. J., & Goodwin, J. S. (2018). Testosterone prescribing in the United States, 2002–2016. JAMA, 320(2), 200–202. Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., Bunnell, T. J., Tricker, R., Shirazi, A., & Casaburi, R. (1996). The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. The New England Journal of Medicine, 335(1), 1–7. Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018). Testosterone therapy in men with hypogonadism: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 103(5), 1715–1744. Christou, M. A., Christou, P. A., Markozannes, G., Tsatsoulis, A., Mastorakos, G., & Tigas, S. (2017). Effects of anabolic androgenic steroids on the reproductive system of athletes and recreational users: A systematic review and meta-analysis. Sports Medicine, 47(9), 1869–1883. Cinar, V., Polat, Y., Baltaci, A. K., & Mogulkoc, R. (2011). Effects of magnesium supplementation on testosterone levels of athletes and sedentary subjects at rest and after exhaustion. Biological Trace Element Research, 140(1), 18–23. Corona, G., Rastrelli, G., Monami, M., Saad, F., Luconi, M., Lucchese, M., Facchiano, E., Sforza, A., Forti, G., Mannucci, E., & Maggi, M. (2013). Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: A systematic review and meta-analysis. European Journal of Endocrinology, 168(6), 829–843. Demay, M. B., Pittas, A. G., Bikle, D. D., Diab, D. L., Kiely, M. E., Lazaretti-Castro, M., Lips, P., Mitchell, D. M., Murad, M. H., Powers, S., Rao, S. D., Scragg, R., Tayek, J. A., Valent, A. M., Walsh, J. M. E., & McCartney, C. R. (2024). Vitamin D for the prevention of disease: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 109(8), 1907–1947. Dubin, J. M., Jesse, E., Fantus, R. J., Bennett, N. E., Brannigan, R. E., Thirumavalavan, N., & Halpern, J. A. (2022). Guideline-discordant care among direct-to-consumer testosterone therapy platforms. JAMA Internal Medicine, 182(12), 1321–1323. European Association of Urology. (2026). Male hypogonadism. In EAU guidelines on sexual and reproductive health. Guisado-Cuadrado, I., Recacha-Ponce, P., Peinado, A. B., & Romero-Parra, N. (2026). Biochemical responses to experimentally induced short-term low energy availability in athletes: A systematic review. Scandinavian Journal of Medicine & Science in Sports, 36(3), Article e70249. Key, T. J. A., Roe, L., Thorogood, M., Moore, J. W., Clark, G. M. G., & Wang, D. Y. (1990). Testosterone, sex hormone-binding globulin, calculated free testosterone, and oestradiol in male vegans and omnivores. British Journal of Nutrition, 64(1), 111–119. Leproult, R., & Van Cauter, E. (2011). Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA, 305(21), 2173–2174. Lincoff, A. M., Bhasin, S., Flevaris, P., Mitchell, L. M., Basaria, S., Boden, W. E., Cunningham, G. R., Granger, C. B., Khera, M., Thompson, I. M., Wang, Q., Wolski, K., Davey, D., Kalahasti, V., Khan, N., Miller, M. G., Snabes, M. C., Chan, A., Dubcenco, E., Li, X., et al. (2023). Cardiovascular safety of testosterone-replacement therapy. The New England Journal of Medicine, 389(2), 107–117. Messina, M. (2010). Soybean isoflavone exposure does not have feminizing effects on men: A critical examination of the clinical evidence. Fertility and Sterility, 93(7), 2095–2104. Morden, N. E., Woloshin, S., Brooks, C. G., & Schwartz, L. M. (2019). Trends in testosterone prescribing for age-related hypogonadism in men with and without heart disease. JAMA Internal Medicine, 179(3), 446–448. Morton, R. W., Sato, K., Gallaugher, M. P. B., Oikawa, S. Y., McNicholas, P. D., Fujita, S., & Phillips, S. M. (2018). Muscle androgen receptor content but not systemic hormones is associated with resistance training-induced skeletal muscle hypertrophy in healthy, young men. Frontiers in Physiology, 9, Article 1373. Mountjoy, M., Ackerman, K. E., Bailey, D. M., Burke, L. M., Constantini, N., Hackney, A. C., Heikura, I. A., Melin, A., Pensgaard, A. M., Stellingwerff, T., Sundgot-Borgen, J. K., Torstveit, M. K., Jacobsen, A. U., Verhagen, E., Budgett, R., Engebretsen, L., & Erdener, U. (2023). 2023 International Olympic Committee's consensus statement on Relative Energy Deficiency in Sport. British Journal of Sports Medicine, 57(17), 1073–1097. Mulhall, J. P., Trost, L. W., Brannigan, R. E., Kurtz, E. G., Redmon, J. B., Chiles, K. A., Lightner, D. J., Miner, M. M., Murad, M. H., Nelson, C. J., Platz, E. A., Ramanathan, L. V., & Lewis, R. W. (2018). Evaluation and management of testosterone deficiency: AUA guideline. The Journal of Urology, 200(2), 423–432. Prasad, A. S., Mantzoros, C. S., Beck, F. W. J., Hess, J. W., & Brewer, G. J. (1996). Zinc status and serum testosterone levels of healthy adults. Nutrition, 12(5), 344–348. Rao, P. K., Boulet, S. L., Mehta, A., Hotaling, J., Eisenberg, M. L., Honig, S. C., Warner, L., Kissin, D. M., Nangia, A. K., & Ross, L. S. (2017). Trends in testosterone replacement therapy use from 2003 to 2013 among reproductive-age men in the United States. The Journal of Urology, 197(4), 1121–1126. Reed, K. E., Camargo, J., Hamilton-Reeves, J., Kurzer, M., & Messina, M. (2021). Neither soy nor isoflavone intake affects male reproductive hormones: An expanded and updated meta-analysis of clinical studies. Reproductive Toxicology, 100, 60–67. Sagoe, D., Molde, H., Andreassen, C. S., Torsheim, T., & Pallesen, S. (2014). The global epidemiology of anabolic-androgenic steroid use: A meta-analysis and meta-regression analysis. Annals of Epidemiology, 24(5), 383–398. Travison, T. G., Araujo, A. B., O'Donnell, A. B., Kupelian, V., & McKinlay, J. B. (2007). A population-level decline in serum testosterone levels in American men. The Journal of Clinical Endocrinology & Metabolism, 92(1), 196–202. Travison, T. G., Vesper, H. W., Orwoll, E., Wu, F., Kaufman, J. M., Wang, Y., Lapauw, B., Fiers, T., Matsumoto, A. M., & Bhasin, S. (2017). Harmonized reference ranges for circulating testosterone levels in men of four cohort studies in the United States and Europe. The Journal of Clinical Endocrinology & Metabolism, 102(4), 1161–1173. Wankhede, S., Langade, D., Joshi, K., Sinha, S. R., & Bhattacharyya, S. (2015). Examining the effect of Withania somnifera supplementation on muscle strength and recovery: A randomized controlled trial. Journal of the International Society of Sports Nutrition, 12, Article 43. West, D. W. D., & Phillips, S. M. (2012). Associations of exercise-induced hormone profiles and gains in strength and hypertrophy in a large cohort after weight training. European Journal of Applied Physiology, 112(7), 2693–2702. Whittaker, J., & Wu, K. (2021). Low-fat diets and testosterone in men: Systematic review and meta-analysis of intervention studies. The Journal of Steroid Biochemistry and Molecular Biology, 210, Article 105878. Positionspapiere, Behörden und Informationsquellen Deutsche Gesellschaft für Ernährung. (2024). DGE veröffentlicht neues Positionspapier zu veganer Ernährung. Deutsche Gesellschaft für Ernährung. National Institutes of Health, Office of Dietary Supplements. (n.d.). Vitamin B12: Fact sheet for health professionals. Abgerufen am 21. Mai 2026. National Institutes of Health, Office of Dietary Supplements. (n.d.). Vitamin D: Fact sheet for health professionals. Abgerufen am 21. Mai 2026. U.S. Food and Drug Administration. (2025, 28. Februar). FDA issues class-wide labeling changes for testosterone products. U.S. Food and Drug Administration. World Anti-Doping Agency. (2026). The 2026 prohibited list. World Anti-Doping Agency. ‘They've invented a spurious pseudo-disease': Why are so many men being told they have low testosterone? (2026, 10. Mai). The Guardian.  

Prasad Alluri deler med oss fra Markus 4.26-29 om såkornet som blir sådd i jorden og dør. Bonden hviler mens Gud på mirakuløst vis gir nytt liv og rik frukt. Bibeltekst: Mark 4.26-29, Joh 12.24, Jak 5.7, Apg 1.8 Dato: 24. mai 2026 Taler: Prasad Alluri Tid: 26 min

HP’s MD and SVP for India, Bangladesh and Sri Lanka Ipsita Dasgupta joins ET’s Anirban Chowdhury in the latest Corner Office Conversation to discuss why India’s PC story is still in its early stages — and how AI PCs, creators, SMEs and students could drive the next wave of growth. She explains why HP sees “a PC in every child’s hands” as a national opportunity, how AI-powered computing could change productivity for enterprises and creators alike, and why India may emerge as a critical manufacturing and innovation hub in the global tech supply chain. She also speaks candidly about women in leadership, risk-taking, workplace culture and building communities that help women succeed in tech.You can follow Anirban Chowdhury on his social media: X and LinkedinListen in to the episode of Corner Office Conversation with Sridhar Vembu, CEO, of Zoho Corporation, Corner Office Conversation with Gunjan Soni, Country Managing Director, Youtube India, Corner Office Conversation with G.V. Prasad, Co-Chairman and Managing Director Dr Reddy’s Laboratories Ltd, Corner Office Conversation with Rajan Anandan, Managing Director, Peak XV & Surge and much more. Catch the latest episode of “Corner Office Conversation” on: Spotify, Amazon Music, Apple Podcasts,and wherever you get your podcasts from.See omnystudio.com/listener for privacy information.

Dr. Jonathan Howard (neurologist and author) and science journalist Wendy Orent return for another sharp, unsparing look at the state of U.S. public health policy. In this episode, the hosts unpack the surprise withdrawal of Casey Means as surgeon general nominee, her replacement by Fox News commentator and MSKCC breast imaging chief Dr. Nicole Saphier, and what the shuffle signals about the fracturing of the MAHA coalition. They dig into Saphier's contradictory record — pro-vaccine statements from 2020 and 2021 set against more recent anti-vaccine messaging, her supplement business (DropRx), and her now-deleted social media posts criticizing Trump and Elon Musk. From there, the conversation turns to the FDA's blocked publication of research showing the COVID and shingles vaccines are safe, the apparent role of former FDA vaccine office chief Dr. Vinay Prasad, and reporting that FDA Commissioner Marty Makary's job is in jeopardy. The episode also covers a small piece of good news — NIH program director Jenna Norton being reinstated after Jay Bhattacharya placed her on administrative leave for organizing the Bethesda Declaration — alongside disturbing developments: RFK Jr. clearing the path for minors to use tanning beds, and the militarized arrest of 78-year-old retired NIH scientist Dr. David Morens. Howard and Orent close on what the Morens arrest reveals about where lab leak conspiracy thinking has led American science and the rule of law. Hosts Dr. Jonathan Howard: Neurologist, professor, and author who writes prolifically on COVID misinformation and public health policy. Wendy Orent: Science journalist and author specializing in infectious disease, evolutionary biology, and public health. Episode Timestamps [00:00] Welcome and Atlanta weather check-in [00:35] Casey Means out, Nicole Saphier in as surgeon general nominee — what it signals about MAHA [01:30] Saphier's role at Memorial Sloan Kettering and her integrative medicine push [02:50] The 2021 WSJ op-ed with Marty Makary: a 10-fold error on pediatric COVID hospitalizations that was never corrected [06:30] Saphier's video opposing COVID vaccines for healthy children — and the framing of myocarditis as a fate worse than death [09:20] Saphier's earlier pro-vaccine statements from 2020 and 2021, and why MAHA now resents her [11:15] DropRx supplements: the surgeon general nominee's tincture business [12:30] Brandy Zadrozny's reporting on Saphier's book and her past criticism of the Plandemic film [13:10] Wendy watches Plandemic so you don't have to: Judy Mikovits and the anti-vaccine machine [14:50] CNN reports Saphier purged posts critical of Trump and Musk before her nomination [15:50] The most disturbing Saphier clip: 'DOGE is one of the greatest things to happen in U.S. history' while telling cancer researchers to 'just pause' [16:50] Harvard's November 2025 finding: hundreds of thousands of deaths from the USAID shutdown [18:20] Good news: Jenna Norton reinstated at NIH after Jay Bhattacharya tried to fire her over the Bethesda Declaration [19:30] Greg Gonsalves on scientists who cooperate with authoritarian science policy [20:10] FDA blocked publication of research showing the COVID and shingles vaccines are safe [21:30] Vinay Prasad: the censorship critic who became a censor [22:30] Why are these people opposed to the shingles vaccine? Howard and Orent on herpes zoster, strokes, and ophthalmic complications [23:50] New evidence: recombinant zoster vaccine linked to reduced dementia risk in adults 65+ [26:10] Marty Makary's FDA in chaos — WSJ, Bloomberg, and Politico reporting on a possible shakeup [28:00] Trump pressures the FDA to approve flavored vapes; ENDS authorization issued the same day [31:00] Makary's interview defending the Replimmune metastatic melanoma rejection — and getting caught in the contradiction [33:30] Who's really driving the FDA shakeup? Biotech investors, not patients [35:30] RFK Jr. clears path for minors to use tanning beds, and what dermatologists are saying [36:30] The arrest of Dr. David Morens: a 78-year-old retired NIH scientist, federal agents, tactical gear, and a strip-search [38:30] Lysenkoism revisited — what the lab leak conspiracy was always going to lead to [40:30] Closing thoughts and sign-off Key Discussion Points The Nicole Saphier Nomination Casey Means was withdrawn as surgeon general nominee and replaced by Dr. Nicole Saphier, head of breast imaging at Memorial Sloan Kettering Cancer Center and a frequent Fox News medical commentator. Howard revisits Saphier's December 2021 Wall Street Journal op-ed with Marty Makary, which understated pediatric COVID-19 hospitalizations by roughly a factor of 10 because the authors did not realize covid.net data only covered about 10 percent of the U.S. population. The error has never been corrected. Saphier's pre-nomination digital footprint included pro-vaccine statements from 2020 and 2021 alongside more recent anti-vaccine content, criticism of Trump and Elon Musk that has since been purged, and a personal supplement line called DropRx. FDA Censorship of Vaccine Safety Research The FDA blocked publication of internal research finding that the COVID-19 and shingles vaccines are safe, with reporting suggesting Dr. Vinay Prasad's office was involved in the decision before he left the agency. Howard points out the irony: Prasad built much of his public profile complaining about scientific censorship, then engaged in censorship the moment he held FDA power. New peer-reviewed research continues to show the recombinant zoster (shingles) vaccine is associated with reduced dementia risk in adults aged 65 and older, even as senior officials downplay or block such findings. Marty Makary on Thin Ice Multiple outlets — the Wall Street Journal, Bloomberg, NOTUS, and a Rachel Bade scoop — report Makary is at risk of being removed as FDA Commissioner over conflicts with the White House and his handling of rare-disease drug approvals. The same day Trump publicly pressured the FDA on flavored vapes, the agency issued a press release authorizing new ENDS (electronic nicotine delivery systems) products. In a 15-minute interview, Makary defended the rejection of Replimmune's metastatic melanoma drug by attributing it to career FDA scientists, but the journalist surfaced earlier indications that the initial review team had recommended approval. A Rare Piece of Good News NIH program director Jenna Norton, a key organizer of the Bethesda Declaration, was reinstated after Dr. Jay Bhattacharya placed her on administrative leave. A judge also reinstated several FEMA employees in the same ruling. The Arrest of Dr. David Morens Federal agents in tactical gear and bulletproof vests arrested Dr. David Morens, a 78-year-old retired NIH influenza researcher and former aide to Dr. Anthony Fauci, at his home over allegations he used a private email account to discuss official business and avoid FOIA disclosure. According to reporting in Science, Morens was strip-searched, handcuffed, and driven roughly 65 kilometers for fingerprinting and booking. Howard and Orent frame the arrest as the predictable endpoint of years of lab leak conspiracy rhetoric, and as a clear case of selective political prosecution. Mentioned in This Episode Wall Street Journal op-ed: 'Should You Vaccinate Your Five-Year-Old?' by Nicole Saphier and Marty Makary, December 3, 2021 Plandemic (2020 anti-vaccine film featuring Judy Mikovits) Make America Healthy Again (book by Nicole Saphier) Harvard study, November 2025, on deaths attributable to the USAID shutdown Greg Gonsalves essay on Vichy scientists Bethesda Declaration Alyssa Finley, Wall Street Journal: 'President Trump's Marty Makary Problem' Bloomberg: 'Paranoia, Turmoil and Backlash Inside Marty Makary's FDA' Rachel Bade: 'Scoop: Makary's Job in Jeopardy as White House Considers FDA Shakeup' Liz Esely White, Wall Street Journal: 'Trump Pressures FDA Commissioner to Approve Flavored Vapes' Los Angeles Times: 'RFK Jr. clears path for minors' use of tanning beds, much to the dismay of dermatologists' Science: 'Guns and bulletproof vests: How federal agents arrested a Fauci aide' Brandy Zadrozny — reporting on Nicole Saphier

In this episode of In the Line of Fire with Saraj, Prasad Bhamidipati shares powerful insights on leadership, AI, transformation, passion, healthcare innovation, and the future of work.From building empowered teams to reimagining industries through AI-first thinking, this conversation explores how leaders must adapt, evolve, and lead in context.Prasad also shares the vision behind CuraWay.ai — an AI-powered healthcare platform designed to improve access to quality healthcare globally through technology, empathy, and intelligent matching.Key themes include:• Passion-driven leadership• AI-first business transformation• Learning and unlearning• Future-ready organizations• Human-centered innovation• Leadership in times of disruption• Skills required for the next generationA deeply insightful conversation for CEOs, CXOs, founders, professionals, and future leaders navigating the age of AI.Hosted by Saraj.Real Leaders. Real Conversations. Real Insights.

When esteemed economist and author Eswar Prasad set out to write his latest book, it was to be about the promise of some recent trends within the world's economic and power structures, but he found something darker. The Doom Loop is about what happens when the positive forces that normally bring stability begin to work against each other. In this podcast, Prasad says that the dynamics of this negative feedback loop have led to the erosion of institutions across the globe. Transcript: https://bit.ly/4d5i8Df  

Aakashdeep - Jayshankar Prasad - घीसू - जयशंकर प्रसाद - Suno Kahani #jayshankarprasad #jayshankarprasad #jayshankarprasadkikahani #jaishankarprasadkikahani #jaishankarprasadkikahaniyan #jaishankarprasadkikahani #hindikahaniyan #hindistories #sunokahani #hindi #audiobook#kahani #kahaniyan #jayshankarprasad#sunokahani #hindi #kahani #kahaniyan #jayshankarprasad #sunokahani #hindi #kahani #hindikahani#kahaniyan #jayshankarprasadkikahani #jayshankarprasad #jaishankarprasad #jayshankarprasadkikahaniyan

This episode features "The Trajectory of Memory is Forward" written by Rajeev Prasad. Published in the April 2026 issue of Clarkesworld Magazine and read by Kate Baker. The text version of this story can be found at: https://clarkesworldmagazine.com/prasad_04_26 Support us on Patreon at https://www.patreon.com/clarkesworld/membership

Jonathan and Wendy unpack the most surprising political move of Trump's second term: the nomination of Dr. Erica Schwartz — a physician, lawyer, former Coast Guard public health official, and unapologetic architect of military vaccine mandates — to run the CDC. Praised by figures like Jerome Adams, Vin Gupta, and Dorit Reiss, and openly loathed by RFK Jr.'s attack-dog attorney Aaron Siri, Schwartz's selection is read as a signal that the White House is quietly sidelining Kennedy ahead of the midterms and trying to win back the saner corners of the GOP. From there, the hosts dig into the widening fault lines inside MAHA: Marty Makary vs. Robert Malone — the "10 children killed by the COVID vaccine" report Makary promised has never materialized, and Malone is now publicly accusing him of the exact cover-up Makary accused his predecessors of. Vinay Prasad's exit from the FDA — his much-hyped randomized controlled trial of the Pfizer COVID vaccine in healthy 50–64-year-olds failed to recruit, proving (again) that tweeting about RCTs is easier than running them. Jonathan plays Prasad's own year-old promise back against him. The rumored FDA replacement — ophthalmologist and Twitter personality David Hooman, whose COVID-vaccine misinformation record would send exactly the wrong signal. Jay Bhattacharya on the rally circuit — CPAC, Turning Point USA, Kennedy rallies, DeSantis rallies — all while insisting "science shouldn't be political." Plus his role in suppressing a CDC vaccine-safety study and the UCSF faculty petition to block Prasad's return. The peptides free-for-all at the FDA, and why Kennedy still has enough juice to throw bones to his wellness-grifter base. Also: measles in Utah, a Moab travel detour, and a plea to every journalist, clinician, and listener still pushing back. MAHA is on its back foot — the job now is to keep the pressure on.

To know more, check out:https://sskl.co.in/https://kanchivml.com/https://brandmandir.com/Guest Suggestion Form: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://forms.gle/bnaeY3FpoFU9ZjA47⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Disclaimer: This video is intended solely for educational purposes and opinions shared by the guest are his personal views. We do not intent to defame or harm any person/ brand/ product/ country/ profession mentioned in the video. Our goal is to provide information to help audience make informed choices. The media used in this video are solely for informational purposes and belongs to their respective owners.(00:00) - Intro(02:46) - How can one build a saree business in India?(17:19) - What would 30 people in the backend do in a saree business?(21:14) - Was there a strategy behind targeting the middle class and upper middle class?(32:08) - Introducing international shopping experience to Indians(43:16) - How does he keep track of things happening in his store?(45:00) - One or two AI patterns that surprised him(50:51) - What's the biggest mistake he made and regrets?(58:08) - How does he beat giants like Tata & Reliance?(1:00:00) - Top 3 data points which are very important for him(1:02:52) - India's wedding economy(1:06:40) - Gen Zs are going to keep our culture alive(1:10:20) - Have sarees moved from daily wear to occasion wear?(1:15:44) - Are ready draped sarees becoming a trend?(1:17:20) - How he manages inventory(1:18:28) - Is he facing competition online?(1:23:03) - One opportunity in his industry in which people can build a business(1:26:26) - What's one problem in his life he would pay someone to solve?(1:27:41) - BTS(1:28:22) - OutroIn today's episode, we sit down with Nagakanaka Durga Prasad Chalavadi, Founder and Managing Director of SSKL.We talk about how he started by selling just 300 sarees from a basement, why the saree market is still highly unorganized, and how he identified a large opportunity in it.The conversation also covers how he scaled using cluster-based expansion, why controlling the supply chain improved both cost and quality, and how trust and pricing play an important role in emotional categories like sarees.He also explains how systems like data, MIS, and the smart use of AI in retail can improve sales, forecasting, and customer understanding. This episode breaks down practical lessons on building and scaling a business in India.Subscribe for more such conversations.Follow Nagakanaka Durga Prasad Chalavadi here: Instagram: https://www.instagram.com/prasadchalavadiofficialFollow VaraMahalakshmi Silks here:Instagram: https://www.instagram.com/kanchivmlsilks/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠About Raj ShamaniRaj Shamani is an Entrepreneur at heart that explains his expertise in Business Content Creation & Public Speaking. He has delivered 200+ speeches in 26+ countries. Besides that, Raj is also an Angel Investor interested in crazy minds who are creating a sensation in the Fintech, FMCG, & passion economy space.

In his new book, 'The Doom Loop: Why the World Economic Order Is Spiraling into Disorder,' Eswar Prasad writes that "economic, political, and geopolitical factors are fuelling a doom loop, breeding turmoil rather than stability, disarray rather than order." Prasad joins EconoFact Chats to discuss why forces once expected to foster shared prosperity -- globalization, multilateral institutions and competition -- are instead driving instability, and why the erosion of domestic institutions makes this moment more dangerous than previous periods of volatility. Eswar is a Professor at Cornell University and a Senior Fellow at the Brookings Institution. He previously served as head of the International Monetary Fund's China division.

Listen to our weekly report on the major news in Nepal over the past seven days. - गएका सात दिन यता नेपालमा के-के भयो? थाहा पाउन हाम्रो साप्ताहिक नेपाल डायरी सुन्नुहोस्।

Shiva Prasad Ghimire is a Nepali Businessman, the Founder and Chairman of SG Group, a conglomerate spanning energy, automobiles, media, and infrastructure sectors.

In this episode, the hosts unpack the controversial exit of Vinay Prasad from the FDA and what it reveals about fractures inside the MAHA coalition and the broader Trump-era health policy landscape. They examine the disputes surrounding rare-disease drug approvals—particularly Huntington's gene therapy—alongside ongoing battles over COVID vaccines, regulatory standards, and public trust in federal health agencies. The discussion also explores how political alliances, pandemic-era commentary, and conflicts with patient advocacy groups ultimately contributed to Prasad's downfall and what it may signal for the future of vaccine policy and biomedical regulation in the U.S. Connect with us further on https://sciencebasedmedicine.org/author/jonathanhoward/  The Fine Print The content presented in the "We Want Them Infected" Podcast and associated book is intended for informational and educational purposes only.    The views and opinions expressed by the speakers, hosts, and guests on the podcast do not necessarily reflect the views of the creators, producers, or distributors. The information provided in this podcast should not be considered as a substitute for professional medical, scientific, or legal advice. Listeners and readers are encouraged to consult with relevant experts and authorities for specific guidance and information.   The creators of the podcast and book have made reasonable efforts to ensure that the information provided is accurate and up to date. However, as the field of medical science and the understanding of the COVID-19 pandemic continue to evolve, there may be new developments and insights that are not covered in this content.   The creators are not responsible for any errors or omissions in the content or for any actions taken based on the information provided. They disclaim any liability for any loss, injury, or damage incurred by individuals who rely on the content.   Listeners and readers are urged to use their judgment and conduct their own research when interpreting the information presented in the "We Want Them Infected" podcast and book. It is essential to stay informed about the latest updates, guidelines, and recommendations related to COVID-19 and vaccination from reputable sources, such as government health agencies and medical professionals. By accessing and using the content, you acknowledge and accept the terms of this disclaimer.   Please consult with appropriate experts and authorities for specific guidance on matters related to health, science, and the COVID-19 pandemic.  

Mere Gurudev Ka Prasad Tumhe Dena Chahta Hun : Pujya Sant Shri Asharamji Bapu Satsang

Pink Sheet Executive Editor Derrick Gingery, Managing Editor Bridget Silverman and Editor-in-Chief Nielsen Hobbs discuss potential directions for the US Food and Drug Administration's Center for Biologics Evaluation and Research after the departure of Director Vinay Prasad (:32), including similarities between the center's leadership issues and the staffing problems in the Harry Potter saga's Hogwarts School of Witchcraft and Wizardry (7:48), as well as the potential policy implications (10:11). They also discuss the contributions of the agency's Real-Time Oncology Review (RTOR) pilot program to the quick reviews of two Commissioner's National Priority Voucher (CNPV) awardees (17:19). More On These Topics From The Pink Sheet US FDA's Vinay Prasad, Controversial CBER Director, Leaving In April: https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/us-fdas-vinay-prasad-controversial-cber-director-leaving-in-april-DJO7ACE73RCNTLZKQWCN2S26LM/ US FDA's CNPV Approvals Ride RTOR Pilot's Coattails: https://insights.citeline.com/pink-sheet/pathways-and-standards/review-pathways/us-fdas-cnpv-approvals-ride-rtor-pilots-coattails-3HEGU5MDWJEG7OYHSZQR6TE5NM/

Mere Gurudev Ka Prasad Tumhe Dena Chahta Hun : Pujya Sant Shri Asharamji Bapu Satsang

After Friday's news that Center for Biologics Evaluation & Research Chief Vinay Prasad will leave the FDA—again—at the end of April, stocks for several rare disease drug developers popped. UniQure, in particular, was up 51% in premarket trading on Monday. Prasad in a meeting last Thursday with select journalists called the biotech's Huntington's treatment AMT-130 a “failed” therapy, according to STAT News. Shares of Replimune and REGENXBIO—which have suffered rejections during the past year—also rose.One person who is not impressed with the plethora of rare disease drug rejections of late—H.C. Wainwright said in a note Tuesday that there have been at least five cell and gene therapies they believe could have been approved under prior FDA officials—is Wisconsin Senator Ron Johnson. Tuesday, Bloomberg News reported that Johnson has launched an investigation into these recent denials.Johnson called the FDA's request that uniQure conduct a sham surgery-controlled trial of AMT-130 “bureaucratic idiocy,” according to the publication. Meanwhile, uniQure and the FDA appear to be on different pages regarding the design of this prospective trial, with uniQure Chief Medical Officer Walid Abi-Saab referring to a 10-12 hour surgery during which [burr] holes would be drilled in patients' skulls and Prasad claiming on a media call last week that it would require only “one to three nicks in the scalp.”In other news, no episode of The Weekly would be complete without our weekly weight loss segment. Roche and Zealand Pharma's amylin analog fell short of Eli Lilly's rival candidate eloralintide; AbbVie reported what analysts called “competitive” results, with its amylin analog eliciting nearly 10% weight loss at 13 weeks in a Phase 1 trial; and Regeneron touted a much-needed Phase 3 win for Hansoh-partnered dual GLP-1/GIPR agonist olatorepatide in China. Beyond data, Novo Nordisk and Hims & Hers are together again, with Novo striking a deal to sell its injectable and oral GLP-1 medicines through the telehealth provider.Elsewhere on the business side of biopharma, experts are reporting a cut-throat atmosphere behind doors on the M&A front as the supply of companies available to buy dwindles.

What makes a handbag truly worth carrying every day? We sit down with Shay Prasad of Bags for Breakfast to explore how years on the retail floor shaped her approach to bags as tools for life—not just status symbols. From writing deep-dive Substack essays to launching a curated vintage shop, Shay explains how storytelling, condition knowledge, and retail anthropology turn casual shoppers into thoughtful collectors. Along the way, she shares how to judge patina versus wear, why function matters as much as heritage, and how understanding the history behind iconic houses helps buyers make smarter, more sustainable choices.Key Takeaways: • Function beats fantasy — A great bag works with your real life. • Patina has value — “Loved” pieces often carry more character than pristine ones. • Context sharpens taste — Knowing a brand's history leads to better buying decisions.

Let's know what you liked and learnt! In this episode, Swami is in conversation with Professor T Prasad of IIM Bombay also known as ‘Mandi' Sir. Prof Prasad challenges the conventional model of higher education and argues that real learning happens not through lectures and exams, but through action, experimentation, and value creation. Drawing from decades of teaching experience, he explains how students can move from passive learning to entrepreneurial thinking by engaging directly with markets, customers, and real-world problems. He shares the philosophy behind his “Mandi” approach to learning, where students are encouraged to start companies, test ideas, sell products, and learn from failures while still in college. By connecting classroom knowledge with practical experimentation, he believes education can shift its focus from producing job seekers to nurturing self-reliant creators and job givers.⭐ 5 Key Takeaways1. Learning Happens Through ActionTrue understanding comes when students apply ideas in the real world, experiment with them, and create value rather than simply studying theory.2. The Market is the Best ClassroomWhen students interact with real customers and markets, they naturally learn concepts like pricing, positioning, and value creation that textbooks struggle to teach.3. Education Should Create Job CreatorsThe goal of higher education should not be only to produce employees but to nurture individuals who can build enterprises and create opportunities for others.4. Assignments Should Connect Across DisciplinesInstead of fragmented coursework, learning becomes powerful when assignments across subjects combine to build a real venture or project.5. Startups Can Be a Powerful Learning ToolBy encouraging students to start companies during their education, institutions can create a practical environment where entrepreneurship, leadership, and resilience are learned firsthand.  ⏱️ Timestamps00:03:13 — “Education Must Move From Pedagogy to Self-Driven Learning”00:06:17 — “The Question Is Not the Top 1% — It's the Other 99%”00:09:26 — “Learning Is Not Listening — Learning Is Selling”00:17:14 — “The Market Teaches What the Classroom Cannot”00:25:41 — “From Information to Value Creation — That Is the Real Exam”00:31:48 — “Our Education System Produces Employees, Not Creators”00:35:20 — “Startups Should Be a Part of Education”00:37:41 — “Entrepreneurship Should Be Designed, Not Left to Chance”00:39:17 — “Truth, Self-Reliance, and Non-Violence Define Success”00:40:04 — “Don't Become Another Brick in the Wall”00:41:03 — “Gandhi, Ambedkar, and Visvesvaraya Still Teach Us Today”#entrepreneurship, #educationreform, #studentstartups, #experientiallearning, #highereducation, #startupindia, #entrepreneurialmindset, #learningbydoing, #futureofeducation, #contrarianthinking, #iimbombay, #ContraMindsPodcast, #mandisirThis episode was made possible by the great folks at https://goaffortless.ai.⁠Effortless⁠ has been designed to be user-friendly, aiding you in your journey to streamline financial tasks. Experience the convenience of achieving e-Invoicing and

The second ousting of Vinay Prasad from FDA in the past eight months won't lead to major changes at the agency, other than selecting a successor tasked with keeping FDA out of the news ahead of the coming midterm elections. On the latest BioCentury This Week podcast, Washington editor Steve Usdin lays out why the former CBER director was pushed out at FDA and what's next for the agency following his departure.BioCentury's editors also discuss the next wave of therapies for idiopathic pulmonary fibrosis, including whether new candidates might go beyond slowing disease to halt or even reverse progression, the biological complexity that makes fibrosis so challenging, and what the 20-plus Phase II programs could teach the field about fibrosis biology.Also up for discussion were recent clinical wins — as well as more complicated readouts — from psychedelic therapies; plus the latest data updates from obesity treatments, with a focus on amylin agonists.View full story: https://www.biocentury.com/article/658698#FDA #IdiopathicPulmonaryFibrosis #PsychedelicTherapies #ObesityDrugs #AmylinAgonists00:00 - Introduction01:56 - Prasad's Departure15:27 - Fibrosis Therapies23:35 - Psychedelics Clinical Catalysts28:24 - Obesity UpdatesTo submit a question to BioCentury's editors, email the BioCentury This Week team at podcasts@biocentury.com.Reach us by sending a text

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of significant events and trends shaping the industry landscape, offering insight into the dynamic interplay between scientific innovation, regulatory challenges, and strategic growth.Starting with the recent departure of Vinay Prasad from the U.S. Food and Drug Administration, particularly from his role as director of the Center for Biologics Evaluation and Research (CBER). Prasad's tenure, though brief, left an indelible mark characterized by controversy and debate over regulatory decisions. His leadership coincided with significant advancements in biologics and gene editing technologies, like CRISPR, highlighting the complexities in balancing innovation with safety standards. Under Prasad's guidance, the FDA faced challenges in navigating these rapid advancements while maintaining rigorous oversight to ensure that new therapies are both effective and safe for public use. Prasad's resignation signals potential shifts in regulatory philosophy at CBER. The biotech industry is watching closely to see how new leadership will influence ongoing and future evaluations of biologics. The change presents an opportunity to reassess how regulatory bodies can better adapt to scientific advancements while ensuring that patient safety remains paramount. The issues faced during Prasad's tenure underscore the need for transparent decision-making and open communication with stakeholders, which are vital for maintaining trust in regulatory processes.Meanwhile, Pfizer has made a strategic entry into the Chinese obesity market with the approval of a GLP-1 drug developed alongside Sciwind Biosciences. This approval represents not only a significant step for Pfizer but also underscores a broader global focus on obesity management. The efficacy of GLP-1 receptor agonists in weight regulation has opened up new market opportunities, highlighting the growing importance of metabolic health solutions in addressing public health challenges.In other news, Johnson & Johnson's Tecvayli-Darzalex combination therapy has received its third national priority recognition from the FDA for treating multiple myeloma. This recognition reflects promising Phase 3 trial results and underscores the critical role of innovative combination therapies in improving outcomes for complex hematologic malignancies. The success of such therapies illustrates how targeted approaches can significantly enhance treatment efficacy and patient quality of life.Strategic acquisitions continue to reshape industry dynamics. Servier's $2.5 billion acquisition of Day One Biopharmaceuticals aims to strengthen its rare cancer portfolio, including a promising glioma drug, Ojemda. This move highlights Servier's commitment to addressing unmet needs in pediatric oncology and rare diseases, emphasizing a broader industry trend towards focusing on niche therapeutic areas with high potential impact.Regulatory activities are gaining momentum as well, with the FDA set to end a nine-month hiatus in advisory committee meetings by reviewing AstraZeneca's oral selective estrogen receptor degrader Truqa. As AstraZeneca seeks to enhance its oncology pipeline, this review signals ongoing innovation in hormone-based cancer therapies and reflects a renewed emphasis on bringing novel treatments to market efficiently.Additionally, Glenmark Pharmaceuticals has achieved a significant milestone with FDA approval for its generic version of GSK's asthma inhaler Flovent. This development exemplifies efforts to improve access to respiratory treatments by providing cost-effective alternatives to branded medications, potentially reducing healthcare costs while enhancing patient access.On an international scale, Taiwan has announced a substantial investment plan aimed at bolstering its drugSupport the show

Hormones influence every system in the body, from mood and metabolism to sleep, fertility, and the transitions of midlife. In this episode, I'm joined by Vaidya Princy Prasad of Kerala Ayurveda Academy to explore hormone regulation through the classical lens of Ayurveda. Rather than viewing hormones in isolation, we discuss how endocrine balance reflects the state of the doshas, agni, the nervous system, and overall resilience, especially in today's high-stress world. Vaidya Princy shares practical wisdom on building awareness of hormonal fluctuations, supporting the body through stress and burnout, and navigating perimenopause with steadiness and nourishment. In This Episode, We Explore: Why hormone regulation is such a timely focus in modern life How chronic stress and burnout disrupt hormonal balance The relationship between hormones and Vata, Pitta, and Kapha How to observe and track your own hormonal patterns Managing the transition of perimenopause through Ayurveda Ayurvedic herbs that support hormonal health This conversation offers a grounded, holistic perspective on restoring balance and working with your body's natural rhythms rather than against them. Episode Sponsor: This episode is supported by Kerala Ayurveda Academy and Wellness Center and their online store at Kerala Ayurveda Store. If you're looking for high-quality, traditionally prepared Ayurvedic herbal formulas, their products are crafted according to classical Ayurvedic principles and designed to support balance at every stage of life. Check out Kerala Ayurveda Academy here. https://www.keralaayurveda.us/courses/ And as a listener of the podcast, you can receive 10% off your order by using the coupon code Welcome10 at checkout. Visit keralaayurveda.store https://keralaayurveda.store/ Check out Colette's online services:  Online Consultations https://www.elementshealingandwellbeing.com/consultations Group Digestive Reset Cleanse - April 17th, 2026 https://www.elementshealingandwellbeing.com/group-cleanse Private Digestive Reset Cleanse https://www.elementshealingandwellbeing.com/digestive-reset-cleanse Online Daily Habits for Holistic Health Program https://www.elementshealingandwellbeing.com/daily-habits Reset-Restore-Renew Program https://www.elementshealingandwellbeing.com/reset-restore-renew Have questions on Colette's online services? Book a FREE 15 min Services Enquiry Call here. https://www.elementshealingandwellbeing.com/consultations Do I have an accumulation of ama/toxins in my body? Take this quiz to find out https://www.elementshealingandwellbeing.com/resources Stay connected on the Elements social media: Instagram - https://www.instagram.com/elementsofayurvedapodcast/ Facebook - https://www.facebook.com/elementshealingandwellbeing Thank you for listening! If this episode supported you, please consider leaving a review and if you think this information would be helpful to family or friends, please share this episode so we can spread this wisdom of Ayurveda.  Stay tuned and stay aligned with the Elements of Ayurveda Podcast. Thanks for listening!

In The Doom Loop: Why the World Economic Order Is Spiraling into Disorder, Eswar Prasad argues that we are caught in a destructive feedback loop between economics, domestic politics, and geopolitics.Prasad is a professor of Trade Policy and Economics at Cornell University, as well as a Senior Fellow at the Brookings Institution. In his new book, he explores how globalization, international institutions, the rise of “middle power” countries, and technological innovations had the potential to promote shared prosperity—but instead are driving global instability.In his conversation with Nikolaus Lang, global leader of the BCG Henderson Institute, he discusses the breakdown of the rule-based system, implications for trade policy in Europe and elsewhere, and the role AI plays in driving global instability.Key topics discussed: 01:20 | The doom loop driving global instability06:41 | The positive aspects of globalization and middle powers12:02 | Implications for European trade policy15:51 | The breakdown of the rule-based system18:36 | The role of AI and other technologies in the doom loop23:57 | Reasons for remaining optimisticAdditional inspirations from Eswar Prasad:The Future of Money: How the Digital Revolution Is Transforming Currencies and Finance (Belknap Press: An Imprint of Harvard University Press, 2023)

Across more than three decades, UNSW Professor Deo Prasad has shaped the national and global conversation on low carbon living through research, education, policy leadership, and industry collaboration. From pioneering sustainability education in the southern hemisphere to leading Australia's largest built-environment research collaboration through the CRC for Low Carbon Living, his impact spans academia, government, industry, and generations of practitioners worldwide.He talks about his life's work so far, the value of teaching, the importance of building partnerships and how improving sustainability in the built environment is for the benefit of humanity as a whole.

Hon. Ram Prasad Bhandari, the Acting Election Commissioner at the Election Commission Nepal, overseeing 2026 electoral administration and safeguarding transparent democratic processes.

Yoga today is widely understood as a physical practice centered around flexibility and postures. However, its original intent goes far beyond the body. In this episode, we discuss how yoga is not an activity performed for an hour a day, but a lifelong process of refining awareness and transforming the way we perceive ourselves and the world. We examine why suffering has traditionally been the starting point for yogic enquiry, how identity and conditioning shape our experience of reality, and why true yoga involves freeing ourselves from deeply rooted mental patterns rather than simply improving physical capability.Episode Highlights: Why yoga was never meant to be limited to physical posturesThe true goal of yoga: moksha and the removal of sufferingWhy suffering and crisis often initiate deeper spiritual enquiryHow identity itself becomes a source of sufferingThe original definition of asana, according to PatanjaliThe importance of relaxing effort and cultivating awarenessHow yoga transforms personality, perception, and life experienceEpisode Timestamps:00:00 – 05:00: Yoga is more than a physical practice05:00 – 10:00: Yoga as a path, not an activity10:00 – 15:00: The deeper goal of yoga: removal of suffering15:00 – 20:00: Why a crisis often becomes the doorway to yoga20:00 – 25:00: How the mind shapes your entire experience of life25:00 – 30:00: Moksha, desire, and freedom from mental bondage30:00 – 35:00: Chitta vritti and breaking free from conditioning35:00 – 40:00: The illusion of identity and the source of psychological suffering40:00 – 45:00: Spiritual identity and the subtle ego trap45:00 – 50:00: The true meaning of asana according to Patanjali50:00 – 55:00: Effortlessness and the transition into deeper states of awareness55:00 – 60:00: Yoga as a complete system for inner transformationAbout Prasad Rangnekar:Prasad Rangnekar is an internationally respected yoga teacher known for his deep study and teaching of traditional yoga philosophy, especially the Patanjali Yoga Sutras. His work focuses on restoring the original intent of yoga as a path of inner transformation rather than merely a physical practice.About Dr Vignesh Devraj Dr Vignesh Devraj is a fourth-generation Ayurvedic physician and the founder of Sitaram Retreat, Kerala, a space for authentic healing. He is a committed practitioner and researcher of Panchakarma.If you are interested in doing a one-on-one Ayurvedic consultation with Dr Vignesh Devraj please find the details in this link: https://calendly.com/drvignesh/30-minute-session-with-dr-vignesh-devraj-md-ay-istIf you are economically challenged, please use the form provided to request a free Ayurvedic consultation here. (or copy paste this in your browser: https://docs.google.com/forms/d/e/1FAIpQLSd29nHcrC1RssR-6WAqWCWQWKKJo7nGcEm8ITEl2-ErcnfVEg/viewform )BALANCING THE MIGHTY VATA - ONLINE COURSE NOW AVAILABLE Vata is responsible for Prana - the life energy, the nervous system - the master panel of our body, and our emotions. In Ayurveda, it is mentioned that controlling Vata is the most difficult part of healing and recovery. Watch my practical inputs that can be integrated into our life at https://vigneshdevraj.com/balancing-the-mighty-vata/ For further information about Dr Vignesh Devraj, kindly visit www.vigneshdevraj.com and www.sitaramretreat.com Instagram - @sitarambeachretreat | @vigneshdevrajTwitter - @VigneshDevrajWe truly hope you are enjoying our content. Leave your review and subscribe to the podcast, so you'll never miss out on any new episodes. Thanks for your support.Disclaimer: - We strongly do not recommend using the content of these episodes as medical advice for any medical conditions.

In this episode, we dive deep into one of Ayurveda's most fundamental yet misunderstood concepts of Agni. Often translated simply as “digestive fire,” Agni is far more than digestion. It is the body's intelligence to transform food into energy, nutrients into tissues, experiences into learning, and stress into resilience. When this ability weakens, stagnation begins. And stagnation, Ayurveda says, is the starting point of disease.Episode Highlights:Why Agni is considered the essence of lifeHow digestion, immunity, and clarity are all expressions of AgniThe difference between Ama (toxins), Ojas (resilience), and Kapha How does lifestyle shape Agni far more than medicinesWhy are autoimmune diseases not randomSrotas: The intelligent functional pathwaysTimestamps: 00:00 – 05:30: What Truly Governs Health?05:30 – 11:00: What Is Agni Beyond “Digestive Fire”?11:00 – 16:30: Levels of Agni in the Body: From Digestion to Tissue Formation16:30 – 21:30: How to Assess Your Agni?21:30 – 26:30: Agni Beyond the Gut: Mind, Vision, Skin & Metabolism26:30 – 35:30: Strengthening Agni the Right Way35:30 – 41:00: Ancient Bodies in a World of Excess41:00 – 46:30: Mental Stress & Agni Breakdown46:30 – 52:00: Pratyaparadha: When Intellect Turns Against Health52:00 – 57:30: Agni, Ojas & Manas: The Triangle That Runs the Body57:30 – 1:00:00: Autoimmunity Through an Ayurvedic Lens1:00:00 – 1:05:30: Srotas: Rethinking Disease Pathways1:05:30 – 1:11:00: Structural vs Functional Srotas1:11:00 – 1:16:30: How the Body Decides What You Become1:16:30 – 1:21:30: Agni, Dhatu Agni & Why the First Conversion Matters Most1:21:30 – 1:27:00: Can Biomarkers Measure Agni? 1:27:00 – 1:29:30:Treating the Person, Not the ReportAbout Dr Vaidya M PrasadDr. Prasad M, a postgraduate in Ayurveda, has been practicing Ayurveda since 1996. He is working as the Principal and Medical Superintendent of Ashtamgam Ayurveda Chikitsalayam & Vidyapeedham, Vavanoor, Palakkad District, Kerala. He has been doing research-oriented work on the care of autistic children since 2002, which has highlighted him as a pioneer in the ayurvedic system to work with autistic children.About Dr Vignesh Devraj Dr Vignesh Devraj is a fourth-generation Ayurvedic physician and the founder of Sitaram Retreat, Kerala, a space for authentic healing. He is a committed practitioner and researcher of Panchakarma.If you are interested in doing a one-on-one Ayurvedic consultation with Dr Vignesh Devraj please find the details in this link: https://calendly.com/drvignesh/30-minute-session-with-dr-vignesh-devraj-md-ay-istIf you are economically challenged, please use the form provided to request a free Ayurvedic consultation here. (or copy paste this in your browser: https://docs.google.com/forms/d/e/1FAIpQLSd29nHcrC1RssR-6WAqWCWQWKKJo7nGcEm8ITEl2-ErcnfVEg/viewform )BALANCING THE MIGHTY VATA - ONLINE COURSE NOW AVAILABLE Vata is responsible for Prana - the life energy, the nervous system - the master panel of our body, and our emotions. In Ayurveda, it is mentioned that controlling Vata is the most difficult part of healing and recovery. Watch my practical inputs that can be integrated into our life at https://vigneshdevraj.com/balancing-the-mighty-vata/ For further information about Dr Vignesh Devraj, kindly visit www.vigneshdevraj.com and www.sitaramretreat.com Instagram - @sitarambeachretreat | @vigneshdevrajTwitter - @VigneshDevrajWe truly hope you are enjoying our content. Leave your review and subscribe to the podcast, so you'll never miss out on any new episodes. Thanks for your support.Disclaimer: - We strongly do not recommend using the content of these episodes as medical advice for any medical conditions.

Last week, the FDA declined to review Moderna's mRNA-based flu vaccine, with Center for Biologics Evaluation and Research Director Vinay Prasad himself signing the refuse-to-file (RTF) letter. Prasad said Moderna's comparator group “does notreflect the best-available standard of care,” while Moderna pushed back, saying CBER had previously found a standard-dose flu shot to be an “acceptable” comparator. Despite the shocking turn of events, HHS backed Prasad, saying Moderna didn't “follow very clear FDA guidance from 2024.”Regardless of the reasons, the development imperilsModerna's breakeven plans, affecting not just the company's investigational flu vaccine but also a flu-COVID combo shot and other parts of the company's pipeline. And for the broader industry, it highlights the regulatory uncertainty that persists into 2026, even as other countries move full speed ahead with novel modalities.That regulatory uncertainty extended this week to DiscMedicine, whose rare disease drug bitopertin was rejectedby the FDA. The company tried to convince investors that its planned Phase 3 trial would pave the way toward a refiling, but analysts raised concerns that the study was developed with oldFDA leadership. Disc's situation also raises questions about the FDA's Commissioner's National Priority Voucher, which bitopertin had received.Meanwhile, Compass Pathways dropped long-awaited data from two Phase 3 trials of its psilocybin-based COMP360, showing strong durability data that “clearly met the Street's bar for success,” according to Stifel analysts. The company plans to complete a rolling new drug application by the end of the year.Finally, the CDC has been left leaderless, again, with the departure of Jim O'Neill, who had been servingas acting director after the ouster of Susan Monarez last summer. And Sanofi's Paul Hudson was removed as CEO last week. He'll be replaced by Merck KGaA's Belén Garijo, who becomes just the second woman in charge of a Big pharmacompany.

Investing like Darwin means prioritizing survival over growth. This book summary reveals the counterintuitive strategy for enduring market success.

Ainz "Brainz" Prasad is an internationally recognized and award winning music producer. He has worked with musical legends such as Jamie Foxx, Kenny "Babyface" Edmonds, Pink, Snoop Dogg and Miley Cyrus. In addition, Ainz has added film score and music supervision on various film, television and commercial projects to his long list of talents. Instagram @brainzmusicwww.brainzmusic.com

The Truth About Swasthani Brata. In this insightful podcast episode, Hari Prasad Sodari, a renowned Nepali Religious History author, explains the deep spiritual, cultural, and philosophical meaning of Swasthani Katha and Swasthani Brata. The discussion explores the importance of Swasthani, why Swasthani is celebrated every year, and whether this sacred Hindu tradition is followed only by Nepalis or has broader roots in Hindu mythology. Hari Prasad Sodari also challenges modern ideas by discussing how Hindu mythology vs evolution theory presents alternative perspectives through ancient scriptures. The podcast breaks down the steps of celebrating Swasthani Brata, the significance of Salinadhi, and clarifies common questions such as whether reading the first page of the Swasthani book is compulsory. Listeners will gain a clear summary of the Swasthani book, understand the purpose of studying Swasthani every year, and learn why Swasthani puja is more than just rituals—it is a spiritual discipline rooted in Nepali Hindu traditions and ancient Hindu scriptures. This episode is essential for anyone interested in Nepali religious history, Hindu spiritual practices, and the true meaning behind Swasthani Katha. GET CONNECTED WITH Hari Prasad Sodari: Facebook - https://www.facebook.com/hariprasad.sodari/  

Prithvi Narayan Shah & Nepal Unification Explained | Hari Prasad Sodari. Hari Prasad Sodari, a renowned Nepali author and social media personality from Kathmandu, joins this in-depth podcast to discuss the life, vision, and legacy of Prithvi Narayan Shah, the founder of modern Nepal. This episode examines the unification journey of Nepal, the strategic brilliance behind the Gorkha Kingdom, and the historical significance of Divyopadesh in shaping Nepal's national identity. The conversation delves deep into Nepal's history, including conflicts among writers, debates over Prithvi Narayan Shah's good and bad decisions, and whether the capture of the Kathmandu Valley was a Gorkha victory or a national one. Hari Prasad Sodari explains how Prithvi Narayan Shah understood regional geopolitics involving India and China, when the idea of unification truly began, and how he emerged as the central figure in Nepal's political history. This Nepali history podcast also reflects on lessons modern Nepal can learn from Prithvi Narayan Shah's leadership, discipline, respect for elders, and long-term vision. Whether you are interested in Nepal unification, nationalism, or historical leadership, this episode offers valuable insights grounded in research and storytelling. GET CONNECTED WITH Hari Prasad Sodari: Facebook - https://www.facebook.com/hariprasad.sodari/  

Nepal on the World Boxing Map. Nepali boxing is entering a historic era, and this powerful podcast brings together three of the biggest names driving that change — Lal Prasad Upreti, Chandra Bahadur Thapa, and Sujit Kumar Pun Magar (Jet Boxing). Lal Prasad Upreti gained international recognition at the IBA Men's Elite World Boxing Championships, while Chandra Bahadur Thapa made history as the first Nepali to win a medal at the World Boxing Championships. Guiding this rise is Jet Boxing, an IBA and USA Boxing-certified coach and founder of H2O Athletics, who has shaped Nepal's elite fighters. In this episode, they discuss what it truly takes to compete at the world level in boxing, sharing insights on international tournament experience, Asian amateur boxing standards, and the intense fight camps in Rangasala. The conversation dives into strict training routines, no-holiday policies, mental pressure before fights, and how fighters are selected for global tournaments. They also open up about their personal boxing journeys, family reactions, sacrifices, and what boxing means to them beyond medals. With Mission 2026 in focus, this episode captures the grit, discipline, and vision behind the rapid growth of Nepali boxing on the world stage. A must-watch for boxing fans, athletes, and anyone inspired by Nepal's sporting evolution. GET CONNECTED WITH {guest name}: Lal Prasad Upreti: Instagram - https://www.instagram.com/pradipkazi__/ Facebook - https://www.facebook.com/pradip.upreti.102 TikTok - https://www.tiktok.com/@lalprasadupreti Chandra Bahadur Thapa: Instagram - https://www.instagram.com/boxer_chandra/?g=5 Facebook - https://www.facebook.com/chandra.thapa.magar.116183 TikTok - https://www.tiktok.com/@chandrathapa426 Sujit Kumar Pun Magar (Jet Boxing): Instagram - https://www.instagram.com/p/DSePIuIk27O/?img_index=1 Facebook - https://www.facebook.com/Jetslick/ Threads - https://www.threads.com/@jetboxing Tiktok - https://www.tiktok.com/@jetboxing  

Nepal is home to a rich and diverse range of amphibians and reptiles, yet much of this wildlife remains misunderstood. In this podcast episode, we sit down with Bishal Prasad Neupane, a leading Nepali herpetologist and conservationist, to explore the hidden world of snakes of Nepal, frogs, crocodiles, turtles, tortoises, and lizards. Bishal shares how he became interested in reptiles and amphibians, explains the different types of crocodiles in Nepal, and why crocodiles survived even after the extinction of dinosaurs. The conversation dives deep into frog species in Nepal, frog hunting practices, frog dissection in colleges, and ethical concerns around amphibian conservation. We also cover turtles and tortoises in Nepal, the legal aspects of keeping turtles as pets, and the key differences between turtle vs tortoise. A major highlight of this episode is snakes—covering poisonous snakes in Nepal, snake behavior, whether snakes are aggressive, what snakes eat, what anaconda is, and how snake rescue works in Nepal. Most importantly, Bishal explains what to do if a snake bites, how anti venom in Nepal is made, and common myths surrounding snake bites. This episode is essential for anyone interested in wildlife conservation in Nepal, reptile research, snake bite awareness, and understanding Nepal's herpetofauna. GET CONNECTED WITH Bishal Prasad Neupane: Instagram - https://www.instagram.com/bishalneupane0/ YouTube - https://www.youtube.com/@nepalisapien7821/videos  

Angel Studios https://Angel.com/HermanJoin the Angel Guild today where you can stream Thank You, Dr. Fauci and be part of the conversation demanding truth and accountability.  Renue Healthcare https://Renue.Healthcare/ToddYour journey to a better life starts at Renue Healthcare. Visit https://Renue.Healthcare/Todd Bulwark Capital https://KnowYourRiskPodcast.comBe confident in your portfolio with Bulwark! Schedule your free Know Your Risk Portfolio review. Go to KnowYourRiskPodcast.com today. Alan's Soaps https://www.AlansArtisanSoaps.comUse coupon code TODD to save an additional 10% off the bundle price.Bonefrog https://BonefrogCoffee.com/ToddThe new GOLDEN AGE is here! Use code TODD at checkout to receive 10% off your first purchase and 15% on subscriptions.LISTEN and SUBSCRIBE at:The Todd Herman Show - Podcast - Apple PodcastsThe Todd Herman Show | Podcast on SpotifyWATCH and SUBSCRIBE at: Todd Herman - The Todd Herman Show - YouTubeJenner Furst, director of the latest Angel Studios documentary "Thank You Dr. Fauci" joins the show.Episode Links:Thank You Dr. Fauci | Now Streaming | AngelBREAKING/URGENT: mRNA COVID VACCINES KILLED AT LEAST 10 KIDS, THE FDA REPORTS; An FDA review found the shots to blame for the deaths, FDA's new vaccine chief - Dr. Vinay Prasad - told staffers in an email. The agency will tighten standards on new vaccine approval, Prasad wrote.Fauci's Ebola stuntURGENT: mRNA Covid jabs should NEVER have been approved for children or young adults Pfizer, Moderna, the Biden Administration, and everyone in public health who pushed these for kids and teens have blood on their handsUnmask The Truth | Official Clip | Thank You, Dr. Fauci

In his weekly clinical update, Dr. Griffin and Vincent Racaniello protest Vinjay Prasad, head of CBER FDA Nov memo stating administration of the COVID-19 vaccine resulted in 10 children's deaths, but are cautiously delighted by the December memo from those in CBER who dispute this data-less claim, how in 31 states pertussis vaccination rates have declined before Dr. Griffin then deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, of clinical outcomes of oseltamivir versus baloxavir for treating influenza infection, number deaths associated with COVID-19 hospitalizations and disease associated economic burden, where to find PEMGARDA, how to access and pay for Paxlovid, long COVID treatment center, where to go for answers to your long COVID questions, how the German government is committed to research into long COVID and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Industry laments Prasad vaccine memo (Politico) Scoop: FDA vaccine chief's memo cited 10 pediatric Covid-19 vaccine deaths—but the agency's own analysis found 0–7 (Inside Medicine) Whooping cough cases soar as vaccination rates drop (NBC News) Marburg Outbreak in Ethiopia: Current Situation (CDC: Marburg Virus Disease) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles(CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Hundreds quarantined as South Carolina measles outbreak accelerates (Washington Post) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) USrespiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) In call with clinicians, CDC recommends flu vaccines widely (CIDRAP) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season (FDA) Comparison of clinical outcomes of oseltamivir versus baloxavir in outpatients with influenza: a retrospective cohort analysis (International Journal of Infectious Diseases) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) USrespiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Effectiveness of 2024–2025 COVID-19 Vaccines in Children in the United States — VISION, August 29, 2024–September 2, 2025 (CDC:MMWR) Mortality following recovery from COVID-19 hospitalization: A long-term cohort study (International Journal of Infectious Diseases) COVID hospitalization tied to 69% higher risk of death for up to 2 years (CIDRAP) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Comparison of work productivity losses in the United States among employees with COVID-19 at high-risk of severe disease who were untreated or treated with nirmatrelvir/ritonavir (Journal of Medical Economics) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Long-COVID research just got a big funding boost: will it find new treatments?(Nature) Reaching out to US house representative Letters read on TWiV 1280 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

In this episode of THE MENTORS RADIO, Host Dan Hesse talks with Dr. Eswar Prasad, a Professor of Economics at Cornell, a senior fellow at Brookings, and the former head of the IMF's China division, to discuss his book The Future of Money: How the Digital Revolution Is Transforming Currencies and Finance, which was chosen as a Best Book of the Year by The Economist, The Financial Times, Foreign Affairs, ProMarket, and The Week. In The Future of Money, Dr. Prasad argues that we are at an inflection point where technology is redefining what money is, who issues it, and how it moves—pushing us toward a world with less physical cash, and an ecosystem of fintech and crypto innovations that will reshape everything from household payments to the global monetary order. LISTEN TO the radio broadcast live on iHeart Radio, or to “THE MENTORS RADIO” podcast any time, anywhere, on any podcast platform – subscribe here and don't miss an episode! SHOW NOTES: ESWAR S. PRASAD: BIO: BIO: Eswar S. Prasad BOOKS: The Future of Money: How the Digital Revolution Is Transforming Currencies and Finance, by Eswar S. Prasad The Doom Loop: Why the World Economic Order Is Spiraling into Disorder, by Eswar S. Prasad Gaining Currency: The Rise of the Renminbi, by Eswar S. Prasad The Dollar Trap: How the U.S. Dollar TIghtened its Grip on Global Finance, by Eswar S. Prasad WEBSITE: https://www.futureofmoneybook.com/

As 2025 closes, biopharma and healthcare are learning to live on shifting ground. In this special year-end episode of "The Top Line," Fierce reporters take stock of a year defined by federal research cuts, vaccine policy fights and leadership churn at the FDA, then push the conversation forward into the questions that will shape 2026. The through line is that uncertainty has become an operating environment, and the industry is recalibrating in real time. Fierce Biotech’s Gabrielle Masson, joined by Darren Incorvia, traces how funding decisions can narrow the pipeline years before the consequences are visible. Fierce Pharma’s Fraiser Kansteiner sits down with Angus Liu and Eric Sagonowsky to unpack the new center of gravity inside federal agencies, where vaccine recommendations, review norms and new FDA pilots are colliding with questions about capacity and outside influence. From there, Ben Adams and James Waldron bring the lens to Europe, where Jefferies in London captured a cautiously optimistic market still wrestling with tariffs, pricing pressure and investment hesitation. The episode closes with Fierce Healthcare’s Heather Landi and Paige Minemyer sharing their outlook on 2026, from the fight over ACA subsidies and Medicaid headwinds to the next phase of AI adoption, where the promise is real but the payoff may be slower, messier and more uneven than the hype suggests. To learn more about the topics in this episode: 'Unprecedented turmoil' engulfing FDA threatens public health: mRNA coalition speaks out FDA names Tracy Beth Høeg, fresh from vaccine safety probe, as acting head of drug center A dozen former FDA commissioners blast Prasad's proposed vaccine policy changes In letter to Makary, biotech CEOs push for FDA stability and say volatility threatens US innovation NIH grant cuts have disrupted hundreds of clinical trials, study finds 'Alternative history' of the NIH shows how a 40% budget cut may thwart new medicines House passes healthcare affordability bill without subsidy extension AMA: A look at concentration in commercial insurance, MA markets 2025 Outlook: Hospital finances show signs of stability, but rising costs will be a major headwind See omnystudio.com/listener for privacy information.

Angel Studios https://Angel.com/HermanJoin the Angel Guild today where you can stream Thank You, Dr. Fauci and be part of the conversation demanding truth and accountability.  Renue Healthcare https://Renue.Healthcare/ToddYour journey to a better life starts at Renue Healthcare. Visit https://Renue.Healthcare/Todd Bulwark Capital https://KnowYourRiskPodcast.comBe confident in your portfolio with Bulwark! Schedule your free Know Your Risk Portfolio review. Go to KnowYourRiskPodcast.com today. Alan's Soaps https://www.AlansArtisanSoaps.comUse coupon code TODD to save an additional 10% off the bundle price.Bonefrog https://BonefrogCoffee.com/ToddThe new GOLDEN AGE is here!  Use code TODD at checkout to receive 10% off your first purchase and 15% on subscriptions.LISTEN and SUBSCRIBE at:The Todd Herman Show - Podcast - Apple PodcastsThe Todd Herman Show | Podcast on SpotifyWATCH and SUBSCRIBE at: Todd Herman - The Todd Herman Show - YouTubeJenner Furst, director of the latest Angel Studios documentary "Thank You Dr. Fauci" joins the show.Episode Links:Thank You Dr. Fauci | Now Streaming | AngelBREAKING/URGENT: mRNA COVID VACCINES KILLED AT LEAST 10 KIDS, THE FDA REPORTS; An FDA review found the shots to blame for the deaths, FDA's new vaccine chief - Dr. Vinay Prasad - told staffers in an email. The agency will tighten standards on new vaccine approval, Prasad wrote.Fauci's Ebola stuntURGENT: mRNA Covid jabs should NEVER have been approved for children or young adults Pfizer, Moderna, the Biden Administration, and everyone in public health who pushed these for kids and teens have blood on their handsUnmask The Truth | Official Clip | Thank You, Dr. Fauci

Howie and Harlan are joined by Sudhakar Nuti to discuss his work improving healthcare for homeless New Yorkers, as a street-medicine doctor and a population-health leader at NYC Health + Hospitals. Harlan reports on a proposed law that would cut off funding for U.S. scientists who collaborate with colleagues in China; Howie provides updates on the measles outbreak and a leaked FDA memo claiming that COVID-19 vaccines have killed 10 children. Show notes: Science Across Borders Subtitle C—SAFE Research Act "U.S. Congress considers sweeping ban on Chinese collaborations" Sudhakar Nuti NYC Health + Hospitals Street Medicine Institute "Health Care beyond Clinic Walls—Sustaining and Scaling Up Street Medicine" NYC Health + Hospitals: Street Health Outreach & Wellness Mobile Units "Graduate and professional students tackle food insecurity" California Depart of Public Health: Xylazine Measles CDC: Measles Cases and Outbreaks "Tracking U.S. Measles Outbreaks" World Health Organization: Weekly Epidemiological Record, 2025, vol. 100, no. 48 "Winning against measles: five charts that tell a remarkable 24-year story" "Measles deaths down 88% since 2000, but cases surge" FDA Leak "Experts say top FDA official's claim that Covid vaccines caused kids' deaths requires more evidence" "FDA's Prasad tells staffers agency plans to get tougher on vaccine regulation, blames child deaths on COVID shots" "Thoughts on Vinay Prasad's Leaked Email" "Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021" "Fulminant Myocarditis and Cardiogenic Shock Following COVID-19 Infection Versus COVID-19 Vaccination: A Systematic Literature Review" In the Yale School of Management's MBA for Executives program, you'll get a full MBA education in 22 months while applying new skills to your organization in real time. Yale's Executive Master of Public Health offers a rigorous public health education for working professionals, with the flexibility of evening online classes alongside three on-campus trainings. Email Howie and Harlan comments or questions.  

In this episode, Brandon sits down with Seema Prasad, the visionary owner of Miel, one of Nashville's most beloved farm-driven restaurants. Seema is known for her intentional, soulful approach to hospitality, her deep relationships with local farmers and producers, and her commitment to creating a dining experience rooted in integrity, sustainability, and joy.Together, Seema and Brandon dive into:Her collaborative relationship with Chef Jason IaconaHow they approach menu development, seasonality, storytelling, and experimentationWhy honoring ingredients — and where they come from — is at the heart of every plate at MielHow Seema builds long-standing partnerships with local farmersThe responsibility independent restaurants carry in preserving food culture and supporting regional agricultureWhy “slow hospitality” matters now more than everSeema's philosophy on nurturing her teamCreating a workplace grounded in respect, curiosity, and shared valuesWhat she believes the next generation of restaurateurs needs to hearHow the restaurant continues to evolveExciting projects and ideas on the horizonSeema's hopes for Nashville's restaurant scene in the coming yearsThis episode is a beautiful, thoughtful conversation with one of Nashville's most respected independent operators. If you care about farm-to-table dining, restaurant leadership, or the craft of hospitality, you're going to love this one.Listen now and share with someone who loves the stories behind great restaurants.